Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8504091rdf:typepubmed:Citationlld:pubmed
pubmed-article:8504091lifeskim:mentionsumls-concept:C0521324lld:lifeskim
pubmed-article:8504091lifeskim:mentionsumls-concept:C0027096lld:lifeskim
pubmed-article:8504091lifeskim:mentionsumls-concept:C1548779lld:lifeskim
pubmed-article:8504091lifeskim:mentionsumls-concept:C1947902lld:lifeskim
pubmed-article:8504091lifeskim:mentionsumls-concept:C2827499lld:lifeskim
pubmed-article:8504091lifeskim:mentionsumls-concept:C0045917lld:lifeskim
pubmed-article:8504091lifeskim:mentionsumls-concept:C0146894lld:lifeskim
pubmed-article:8504091lifeskim:mentionsumls-concept:C1167624lld:lifeskim
pubmed-article:8504091pubmed:issue22lld:pubmed
pubmed-article:8504091pubmed:dateCreated1993-7-8lld:pubmed
pubmed-article:8504091pubmed:abstractTextThe purine binding site of ATP on skeletal muscle myosin has been photoaffinity labeled with 2-azidoadenosine diphosphate (2-N3ADP). 2-N3ADP was stably trapped at the active site (t1/2 approximately 5 days, 0 degree C) by complexation of the two heavy chain reactive thiols (Cys-697 and Cys-707) with Co(III)phenanthroline. Photoincorporation occurred only in the 23-kDa NH2-terminal tryptic fragment of the heavy chain. Extensive serial digestion of photolabeled subfragment 1 of myosin by trypsin and subtilisin yielded a series of labeled peptides which were purified by HPLC. Sequence and radiolabeling analysis of eight photolabeled peptides all indicated that tryptophan-130 was the only labeled residue. This site of labeling confirms earlier photolabeling studies with the non-nucleotide ADP analogue, 2[(4-azido-2-nitrophenyl)-amino]ethyl diphosphate (NANDP), which also labeled Trp-130 [Okamoto, Y., & Yount, R. G. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 1575-1579]. Comparison of the structures of 2-N3ADP and NANDP indicate that their azido groups can be superimposed if both analogues bind to the active site in an extended conformation in a manner analogous to the anti conformation of ATP.lld:pubmed
pubmed-article:8504091pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:languageenglld:pubmed
pubmed-article:8504091pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:citationSubsetIMlld:pubmed
pubmed-article:8504091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8504091pubmed:statusMEDLINElld:pubmed
pubmed-article:8504091pubmed:monthJunlld:pubmed
pubmed-article:8504091pubmed:issn0006-2960lld:pubmed
pubmed-article:8504091pubmed:authorpubmed-author:YountR GRGlld:pubmed
pubmed-article:8504091pubmed:authorpubmed-author:KuwayamaHHlld:pubmed
pubmed-article:8504091pubmed:authorpubmed-author:GrammerJ CJClld:pubmed
pubmed-article:8504091pubmed:issnTypePrintlld:pubmed
pubmed-article:8504091pubmed:day8lld:pubmed
pubmed-article:8504091pubmed:volume32lld:pubmed
pubmed-article:8504091pubmed:ownerNLMlld:pubmed
pubmed-article:8504091pubmed:authorsCompleteYlld:pubmed
pubmed-article:8504091pubmed:pagination5725-32lld:pubmed
pubmed-article:8504091pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:meshHeadingpubmed-meshheading:8504091-...lld:pubmed
pubmed-article:8504091pubmed:year1993lld:pubmed
pubmed-article:8504091pubmed:articleTitlePhotoaffinity labeling of skeletal myosin with 2-azidoadenosine triphosphate.lld:pubmed
pubmed-article:8504091pubmed:affiliationDepartment of Biochemistry and Biophysics, Washington State University, Pullman 99164-4660.lld:pubmed
pubmed-article:8504091pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8504091pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8504091pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8504091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8504091lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8504091lld:pubmed